yingweiwo

17β-HSD

17β-HSD

17β-HSD related products

Structure Cat No. Product Name CAS No. Product Description
17β-HSD5 inhibitor 1 V123384 17β-HSD5 inhibitor 1 243638-37-1 17β-HSD5 inhibitor 1 is a potent 17β-HSD5 inhibitor with an IC50 of 2.9 nM in HEK-293 cells overexpressing human 17β-HSD5.
17β-HSD5 inhibitor 2 V123385 17β-HSD5 inhibitor 2 1106941-19-8 17β-HSD5 inhibitor 2 is an inhibitor of 17β-hydroxysteroid dehydrogenase 5 (17β-HSD 5) with an IC50 of 40 nM.
17β-HSD5 inhibitor 3 V87260 17β-HSD5 inhibitor 3 948581-46-2 17β-HSD5 inhibitor 3 (Compound 31) is an orally active 17β-HSD5 inhibitor with IC50 of 69 nM.
17β-HSD7-IN-1 V104587 17β-HSD7-IN-1 17β-HSD7-IN-1 (Compound 4) is an inhibitor of 17β-HSD7 and inhibits the formation of estradiol (IC50=63 nM).
3-Acetyl-7-Hydroxycoumarin V107007 3-Acetyl-7-Hydroxycoumarin 10441-27-7 3-Acetyl-7-hydroxycoumarin (Compound 2) is a highly selective 17-β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor.
6-Bromocoumarin V127364 6-Bromocoumarin 19063-55-9 6-Bromocoumarin is a potential antibacterial agent, but it does not inhibit 17β-HSD1.
7-Coumaryl triflate V127541 7-Coumaryl triflate 108530-10-5 7-Coumaryl triflate is a type 1 inhibitor of 17β-hydroxysteroid dehydrogenase.
Dehydrofalcarinol V110964 Dehydrofalcarinol 36150-08-0 Dehydrofacalol is a polyyne compound found in Candida guatemalense and has anticancer activity.
EM 1404 V87258 EM 1404 243836-37-5 EM 1404 is a 17β-HSD5 inhibitor (IC50: 3.2 nM).
ESC1002755 V135250 ESC1002755 2915567-21-2 ESC1002755 is a 17β-HSD10 inhibitor with an IC50 of 19 nM.
FXR/HSD17B13 modulator 1 V136433 FXR/HSD17B13 modulator 1 3067566-36-0 FXR/HSD17B13 modulator 1 is a potent modulator of FXR/HSD17B13.
FXR/HSD17B13-modulator-2 V136434 FXR/HSD17B13-modulator-2 FXR/HSD17B13-modulator-2 is a dual activator of FXR and an inhibitor of HSD17B13. Its EC50 for human FXR is 128 nM and its IC50 for human HSD17B13 is 0.18 μM. It has high selectivity for the relevant nuclear receptor and HSD17B subtype and is effective orally.
Gatuzosiran V116875 Gatuzosiran 2409783-34-0 Gatuzosiran is an siRNA that inhibits the synthesis of 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13) and is used in research on fatty liver disease.
Gatuzosiran sodium V116796 Gatuzosiran sodium Gatuzosiran sodium is an siRNA that inhibits the synthesis of 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13) and is used in research on fatty liver disease.
GPI2A sodium scrambled negative control V136859 GPI2A sodium scrambled negative control The GPI2A sodium scrambled negative control is a negative control with the GPI2A sodium ion sequence scrambled.
HSD17B13-IN-1 V83879 HSD17B13-IN-1 2770246-02-9
HSD17B13-IN-10 V83979 HSD17B13-IN-10 2576696-23-4
HSD17B13-IN-100 V83476 HSD17B13-IN-100 2770246-33-6
HSD17B13-IN-101 V83404 HSD17B13-IN-101
HSD17B13-IN-102 V83526 HSD17B13-IN-102 2770246-34-7
Contact Us